Skip to content

The research on new technologies, new methods, molecular biomarker screening, and clinical applications for early warning, monitoring, and prognosis assessment of early-onset gastrointestinal cancer based on multi-omics

The research on new technologies, new methods, molecular biomarker screening, and clinical applications for early warning, monitoring, and prognosis assessment of early-onset gastrointestinal cancer based on multi-omics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092814
Enrollment
Unknown
Registered
2024-11-25
Start date
2024-11-25
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Cancer

Interventions

The malignant tumor group:None
The benign tumor group:None

Sponsors

The Second Hospital, Cheeloo College of Medicine, Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 49 Years

Inclusion criteria

Inclusion criteria: 1. Age over 18 years old, under 50 years old; 2. Accept gastroenteroscopy. 3. Pathological diagnosis of digestive tract tumor.

Exclusion criteria

Exclusion criteria: 1. The gastrointestinal malignancy foci are not primary foci; 2. Patients with severe central nervous system diseases, respiratory system diseases, autoimmune diseases, chronic renal insufficiency and other diseases, long-term use of immunosuppressants, and severe uncontrolled infections; 3. Patients with active cardiovascular and cerebrovascular diseases, who have had cerebrovascular accidents, myocardial infarction, unstable angina pectoris within 6 months, or New York Heart Association (NYHA) Class II or higher congestive heart failure, and severe arrhythmias that require medical treatment; 4. Patients with positive blood pregnancy test or fertile women who have not undergone pregnancy test, pregnant or lactating women; 5. The patient is participating in other therapeutic clinical trials that cannot provide clear treatment measures or collect treatment information.

Design outcomes

Primary

MeasureTime frame
Overall Survival;Disease Free Survival;Multi-omics;Hematological indicators;Endoscopic data;Pathological data;

Secondary

MeasureTime frame
Baseline information;Dietary patterns;Lifestyle;Aging condition;

Countries

Chin'a

Contacts

Public ContactHonglei Wu

The Second Hospital, Cheeloo College of Medicine, Shandong University

whl20011996@163.com+86 176 6008 0767

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026